ArticleFrontiers in immunology2022

Engineered red blood cells (activating antigen carriers) drive potent T cell responses and tumor regression in mice.

Katarina Blagovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.